NEW_CURA-LEAF_1170x120_OCT

Silvergate Pharmaceuticals

CutisPharma acquires Silvergate Pharmaceuticals, unveils new name

CutisPharma acquires Silvergate Pharmaceuticals, unveils new name

WOBURN, Mass. – CutisPharma announced Wednesday its acquisition of Silvergate Pharmaceuticals and the unveiling of its new corporate brand for the unified company: Azurity Pharmaceuticals. “I am thrilled to announce the combination of two strong companies with a rich legacy meeting the needs of underserved patients, such as children and the elderly,” said Neal Muni,

Silvergate Pharmaceuticals releases Xatmep Oral Solution

Silvergate Pharmaceuticals releases Xatmep Oral Solution

DENVER — Silvergate Pharmaceuticals Inc. has launched Xatmep Oral Solution (methotrexate 2.5 mg/ml), a medication used for leukemia and arthritis in children. Silvergate said Xatmep is the first and only Food and Drug Administration-approved methotrexate oral solution and will be available via an extensive network of pharmacies. Xatmep is indicated for the treatment of acute

Bartell adds Segrave to its board

SEATTLE — Former Walmart vice president of pharmacy Frank Segrave has joined the board of directors at Bartell Drugs. On the drug chain’s board, Segrave replaces Brian Unmacht, who was appointed as president and chief executive officer of Bartell Drugs in April. Unmacht joined Bartell’s management as president in January and has served on the